Zhang W, Chen W, Liu C, Chen S, Lai Y, You S
Diagnostics (Basel). 2025; 15(3).
PMID: 39941179
PMC: 11817956.
DOI: 10.3390/diagnostics15030249.
Mitsuyama Y, Tatekawa H, Takita H, Sasaki F, Tashiro A, Oue S
Eur Radiol. 2024; .
PMID: 39198333
DOI: 10.1007/s00330-024-11032-8.
Li J, Long Q, Ding H, Wang Y, Luo D, Li Z
Adv Sci (Weinh). 2024; 11(16):e2308677.
PMID: 38419366
PMC: 11040388.
DOI: 10.1002/advs.202308677.
Aljahdali S, Azim G, Zabani W, Bafaraj S, Alyami J, Abduljabbar A
Neurosciences (Riyadh). 2024; 29(1):37-43.
PMID: 38195124
PMC: 10827017.
DOI: 10.17712/nsj.2024.1.20230048.
Uddin M, Dhanta R, Pitti T, Barsasella D, Scholl J, Jian W
Cancers (Basel). 2023; 15(13).
PMID: 37444602
PMC: 10341172.
DOI: 10.3390/cancers15133492.
Multiple Brain Tumor Classification with Dense CNN Architecture Using Brain MRI Images.
Ozkaraca O, Bagriacik O, Guruler H, Khan F, Hussain J, Khan J
Life (Basel). 2023; 13(2).
PMID: 36836705
PMC: 9964555.
DOI: 10.3390/life13020349.
Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders.
Reddy D, Abeygunaratne H
Int J Mol Sci. 2022; 23(19).
PMID: 36233034
PMC: 9570151.
DOI: 10.3390/ijms231911734.
Convolutional Neural Network Techniques for Brain Tumor Classification (from 2015 to 2022): Review, Challenges, and Future Perspectives.
Xie Y, Zaccagna F, Rundo L, Testa C, Agati R, Lodi R
Diagnostics (Basel). 2022; 12(8).
PMID: 36010200
PMC: 9406354.
DOI: 10.3390/diagnostics12081850.
Usefulness of dual isotope I-IMP and Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma.
Osawa S, Tosaka M, Horiguchi K, Tokue A, Higuchi T, Tsushima Y
Int J Clin Oncol. 2022; 27(8):1264-1272.
PMID: 35554754
DOI: 10.1007/s10147-022-02171-3.
Biological evaluation of complexes of cyclopentadienyl M(CO) (M = Re, Tc) with high blood-brain barrier penetration potential as brain cancer agents.
Mavroidi B, Kaminari A, Makrypidi K, Shegani A, Bouziotis P, Pirmettis I
Invest New Drugs. 2022; 40(3):497-505.
PMID: 35024984
DOI: 10.1007/s10637-022-01211-z.
Multi-responsive nanofibers composite gel for local drug delivery to inhibit recurrence of glioma after operation.
Zhu Y, Jia J, Zhao G, Huang X, Wang L, Zhang Y
J Nanobiotechnology. 2021; 19(1):198.
PMID: 34217325
PMC: 8255008.
DOI: 10.1186/s12951-021-00943-z.
Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.
Zhang J, Li X, Huang L
Adv Drug Deliv Rev. 2020; 154-155:245-273.
PMID: 32473991
PMC: 7704676.
DOI: 10.1016/j.addr.2020.05.006.
Gadolinium Deposition in Neurology Clinical Practice.
Smith T, Steven A, Bagert B
Ochsner J. 2019; 19(1):17-25.
PMID: 30983897
PMC: 6447198.
DOI: 10.31486/toj.18.0111.
Thermoresponsive nanocomposite gel for local drug delivery to suppress the growth of glioma by inducing autophagy.
Ding L, Wang Q, Shen M, Sun Y, Zhang X, Huang C
Autophagy. 2017; 13(7):1176-1190.
PMID: 28594260
PMC: 5529082.
DOI: 10.1080/15548627.2017.1320634.
Progress and perspectives on targeting nanoparticles for brain drug delivery.
Gao H
Acta Pharm Sin B. 2016; 6(4):268-86.
PMID: 27471668
PMC: 4951594.
DOI: 10.1016/j.apsb.2016.05.013.
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Mittra E, Koglin N, Mosci C, Kumar M, Hoehne A, Keu K
PLoS One. 2016; 11(2):e0148628.
PMID: 26890637
PMC: 4758607.
DOI: 10.1371/journal.pone.0148628.
Development of targeted therapies in treatment of glioblastoma.
Xu Y, Gao P, Sun Y, Duan Y
Cancer Biol Med. 2015; 12(3):223-37.
PMID: 26487967
PMC: 4607828.
DOI: 10.7497/j.issn.2095-3941.2015.0020.